Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study. - Garnero, P.; Sornay-Rendu, E.; Munoz, F.; Borel, O.; Chapurlat, R. (Osteoporosis International, 2013)